SahinSand KaradenizA. Nonalcoholic fatty pancreas disease is associated with subclinical atherosclerosis. Angiology. 2022;73:508-513.
2.
KatsikiNAthyrosVGand MikhailidisDP. Abnormal peri-organ or intra-organ fat (APIFat) deposition: an underestimated predictor of vascular risk?. Curr Vasc Pharmacol. 2016;14:432-441.
3.
KatsikiNand MikhailidisDP. Perivascular adipose tissue: Pathophysiological links with inflammation, atherosclerosis, and thrombosis. Angiology. 2022;73(3):195-196.
4.
KatsikiNand MikhailidisDP. Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice? Anatol J Cardiol. 2017;17:64-65.
5.
WongWKand ChanWK. Nonalcoholic fatty liver disease: a global perspective. Clin Therapeut. 2021;43:473-499.
6.
YaylaÇYaylaKGKaranfilM, et al. The nonalcoholic fatty liver disease and cardiovascular diseases. Angiology. 2020;71:87.
7.
TuranY. The nonalcoholic fatty liver disease fibrosis score is related to epicardial fat thickness and complexity of coronary artery disease. Angiology. 2020;71:77-82.
8.
MuzurovićEMikhailidisDPand MantzorosC. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metab Clin Exp. 2021;119:154770.
FilippatosTDAlexakisKMavrikakiVand MikhailidisDP. Nonalcoholic fatty pancreas disease: Role in metabolic syndrome, “prediabetes,” diabetes and atherosclerosis. Dig Dis Sci. 2022;67(1):26-41
11.
van GeenenEMSmitsMMSchreuderTvan der PeetDLBloemenaEand MulderCJ. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas. 2010;39:1185-1190.
12.
RosenblattRMehtaASnellDHissongEKieransASand KumarS. Ultrasonographic nonalcoholic fatty pancreas is associated with advanced fibrosis in NAFLD: A retrospective analysis. Dig Dis Sci. 2019;64:262-268.
13.
ZhouJLiMLZhangDD, et al. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population. Pancreatology. 2016;16:578-583.
14.
LeeEHKimJYand YangHR. Ectopic pancreatic fat as a risk factor for hypertension in children and adolescents with nonalcoholic fatty liver disease. J Clin Hypertens. 2021;23:1506-1515.
15.
UygunAKadayifciADemirciH, et al. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med. 2015;26:37-41.
16.
OzturkKDoganTCelikkanatS, et al. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2018;30:411-417.
17.
KulSKaradenizADursunİ, et al. Non-alcoholic fatty pancreas disease is associated with increased epicardial adipose tissue and aortic intima-media thickness. Acta Cardiol Sin. 2019;35:118-125.
18.
TakahashiMHoriMIshigamoriRMutohMImaiTand NakagamaH. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans. Cancer Sci. 2018;109:3013-3023.
